• To identify human microbiota species associated with oncohematological diseases
  • To identify mechanisms of colonization resistance thorough metratransciptomic, metaproteomic, metabolomics assays, among others
  • To identify the potential relationship between the use of antibiotics, biodiversity of the microbiota and colonization / infection by opportunistic pathogens.
  • To study the effect of probiotics administration in hematological patients

Leading Researcher